Dáil Éireann Debate, Tuesday - 7 November 2017
870. Deputy Billy Kelleher asked the Minister for Health if Vimizim was discussed at the drugs committee meeting on 14 September 2017; if so, the contents of the conversation; and if he will make a statement on the matter. [47101/17]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
